| Neoptics
is dedicated to offering the most advanced, safest, and most
widely researched refractive solution for presbyopia. Published
clinical results indicate that lens material is safe whereas
the mixed efficacy data discussed in literature underscore the
difficulties in developing a generally functioning intra-corneal
inlay. Historically, most studies report some cases of reduced
UCDVA after device implantation, astigmatism, as well as photic
phenomena (glare, halos) caused by deposits or haze. Explanting
the devices resulted in a regression to the status prior to
surgery in all reported cases.
Supported by a group of carefully selected experts
and guided by its Medical Advisory Board, Neoptics optimized
the four components of the system influencing efficacy:
|
